351410-47-4

Usage

Uses

Used in Pharmaceutical Industry:
(5-Bromo-2-methoxypyridin-3-yl)methanol is used as a key intermediate in the synthesis of various pharmaceuticals for its potential applications in the development of new drugs. Its unique structural features allow for the creation of diverse drug candidates with different therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, (5-Bromo-2-methoxypyridin-3-yl)methanol serves as an essential intermediate in the production of agrochemicals, contributing to the development of innovative agricultural products with enhanced efficacy and selectivity.
Used in Organic Synthesis:
(5-Bromo-2-methoxypyridin-3-yl)methanol is utilized as a versatile building block in organic synthesis, enabling the synthesis of a wide range of organic compounds. The presence of the bromine atom further expands its synthetic utility, allowing for various synthetic transformations and the formation of new chemical entities.
Overall, (5-Bromo-2-methoxypyridin-3-yl)methanol plays a significant role in the fields of organic chemistry, pharmaceutical research, and agrochemical development, owing to its structural diversity, reactivity, and applicability in the synthesis of various compounds.

Upstream product

• 13472-60-1 3,5-dibromo-2-methoxypyridine 
• 122433-41-4 methyl 5-bromo-2-methoxy-3-pyridinecarboxylate 
• 78686-79-0 methyl 2-chloro-5-bromonicotinate 
• 29241-65-4 5-bromo-2-chloronicotinic acid 
• 103058-87-3 5-bromo-2-methoxypyridine-3-carboxaldehyde 

Downstream Products

• 1383990-08-6 2-amino-6-(5-(hydroxymethyl)-6-methoxypyridin-3-yl)-3-phenylquinazolin-4(3H)-one 
• 103058-87-3 5-bromo-2-methoxypyridine-3-carboxaldehyde 

Relevant academic research and scientific papers

NEW MACROCYCLIC LRRK2 KINASE INHIBITORS

Compounds of formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description. Medicaments.

PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS

Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by G

Nitrogen-containing heterocyclic compound as well as preparation method, pharmaceutical composition and application thereof

The invention provides a nitrogen-containing heterocyclic compound as well as a preparation method, a pharmaceutical composition and application thereof, and particularly provides a compound as shownin a formula I which is described in the specification,

Substituted Pyrrolidines and Methods of Use

The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, R4A, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

Substituted Pyrrolidines and Methods of Use

The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

Novel piperidine compouds and drugs containing the same

The present invention provides a novel compound having a superior Na+ channel inhibition activity. Namely, it provides a compound represented by the following formula (I), a salt thereof or a hydrate of them. In the formula, the ring A represents a ring represented by the formula: (wherein R1 represents a hydrogen atom etc.; and R2 represents indicates a hydrogen atom and the like) etc.; W represents an optionally substituted C1-6 alkylene group etc.; Z represents an optionally substituted C6-14 aromatic hydrocarbon cyclic group etc.; and l represents an integer from 0 to 6.